Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GreKo: Ketoconazole for CYP17 inhibition in granulosa cell tumour of the ovary
2012-001948-21Phase 2Terminated
- Sponsor
- Grupo Español de Tumores Huérfanos e Infrecuentes
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ketoconazole in granulosa cell tumor (GCT), sponsored by Grupo Español de Tumores Huérfanos e Infrecuentes. Primary endpoint: Overall response rate. Started May 2012; status: terminated.
02
Drugs
ketoconazole
03
Conditions
granulosa cell tumor (GCT)
Beyond the preview
Go deeper on 2012-001948-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001948-21.